Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    11730394 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed EPAT: Estrogen in the Prevention of Atherosclerosis Trial
Conditions: Atherosclerosis;   Postmenopause
Intervention: Drug: Micronized 17B-estradiol
2 Terminated Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers
Condition: Healthy Symptomatic Menopausal Women
Interventions: Drug: CLIMASTON (drug);   Drug: 17 Beta-estradiol (2mg/day)and (1mg/day);   Drug: placebo

Study has passed its completion date and status has not been verified in more than two years.